Clinical Trials
39 trialsCOSMIC
ASH Research Collaborative
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
National Institutes of Health Clinical Center (CC)
A Study of Ninlaro in Real World Clinical Practice in China
Takeda
NIRVANA
Columbia University
A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients
The First Affiliated Hospital of Soochow University
LOOMIS
Oxford University Hospitals NHS Trust
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Pfizer
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
PeriPharm
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
UNC Lineberger Comprehensive Cancer Center
Mobile Health Device Study for Myeloma Patients
Memorial Sloan Kettering Cancer Center
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Pfizer
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
Pfizer
ORHEO
Hospira, now a wholly owned subsidiary of Pfizer
CoMMpass
Multiple Myeloma Research Foundation
The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures
Centre Hospitalier Universitaire de Nice
GAGNE
University Hospital, Bordeaux
Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyricâ„¢ Flow Cytometer
Becton, Dickinson and Company
Corneal Toxicity in Patients Treated by Belantamab Mafodotin
Centre Hospitalier Universitaire de Saint Etienne
Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
National Institutes of Health Clinical Center (CC)
iTIMM
Institute of Cancer Research, United Kingdom
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
OHSU Knight Cancer Institute
REVIEW
Celgene
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Memorial Sloan Kettering Cancer Center
Testing a Spanish Version of a Patient Toxicity Questionnaire
National Institutes of Health Clinical Center (CC)
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
SWOG Cancer Research Network
Comprehensive Frailty Assessment
Ohio State University Comprehensive Cancer Center
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
The Cleveland Clinic
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
City of Hope Medical Center
Study of DNA Samples From Patients With Multiple Myeloma
Eastern Cooperative Oncology Group
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
Eastern Cooperative Oncology Group
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Vanderbilt University Medical Center
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
UNC Lineberger Comprehensive Cancer Center
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
Duke University
S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
SWOG Cancer Research Network
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Prospective Observational Study on Plerixafor After Chemotherapy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Long-Term Follow Up Study for AMD3100 Patients
M.D. Anderson Cancer Center
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
Case Comprehensive Cancer Center
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Wyeth is now a wholly owned subsidiary of Pfizer